Therapeutic Approaches to Counteract Immediate Blood-Mediated Inflammatory Reaction in Islet Transplantation

This publication has 13 references indexed in Scilit:

• The Transgenic Expression of Human CD39 on Murine Islets Inhibits Clotting of Human Blood
  Transplantation, 2006
• Inhibition of Purinoceptors Amplifies Glucose-Stimulated Insulin Release With Removal of its Pulsatility
  Diabetes, 2005
• Tissue Factor Produced by the Endocrine Cells of the Islets of Langerhans Is Associated With a Negative Outcome of Clinical Islet Transplantation
  Diabetes, 2005
• Tissue Factor and CCL2/Monocyte Chemoattractant Protein-1 Released by Human Islets Affect Islet Engraftment in Type 1 Diabetic Recipients
  Journal of Clinical Endocrinology & Metabolism, 2004
• Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets
  Transplantation, 2004
• Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation
  The Lancet, 2002
• Inhibition of Thrombin Abrogates the Instant Blood-Mediated Inflammatory Reaction Triggered by Isolated Human Islets
  Diabetes, 2002
• DAMAGE TO PORCINE ISLETS OF LANGERHANS AFTER EXPOSURE TO HUMAN BLOOD IN VITRO, OR AFTER INTRAPORTAL TRANSPLANTATION TO CYNOMOLOGUS MONKEYS
  Transplantation, 2000
• Isolated Human Islets Trigger an Instant Blood Mediated Inflammatory Reaction: Implications for Intraportal Islet Transplantation as a Treatment for Patients with Type 1 Diabetes
  Upsala Journal of Medical Sciences, 2000
• Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?
  Diabetes, 1999